Northern Trust’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.2M Buy
804,661
+43,301
+6% +$6.17M 0.01% 803
2025
Q4
$127M Buy
761,360
+47,457
+7% +$7.94M 0.02% 644
2025
Q3
$140M Buy
713,903
+204,172
+40% +$33.6M 0.02% 607
2025
Q2
$46.1M Buy
509,731
+218,841
+75% +$17.3M 0.01% 1150
2025
Q1
$17.4M Sell
290,890
-5,230
-2% -$484K ﹤0.01% 1711
2024
Q4
$39.2M Buy
296,120
+213,343
+258% +$20M 0.01% 1268
2024
Q3
$4.34M Buy
82,777
+31,078
+60% +$1.46M ﹤0.01% 2568
2024
Q2
$3.13M Buy
+51,699
New +$3.59M ﹤0.01% 2654

Other funds holding ALAB

Northern Trust's ALAB Position: Q1 2026 in Review

Northern Trust increased its Astera Labs (ALAB) stake by 5.7% in Q1 2026, buying an estimated $6.17M and bringing the position to 804,661 shares worth $88.2M. The position accounts for 0.01% of the portfolio, ranked #803.

Northern Trust first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $140M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Northern Trust held 804,661 shares of Astera Labs worth $88.2M as of Q1 2026.
  • Northern Trust bought 43,301 Astera Labs shares in Q1 2026, an estimated $6.17M.
  • Astera Labs made up 0.01% of Northern Trust's portfolio in Q1 2026, its #803 holding.
  • Northern Trust first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Northern Trust's Astera Labs position peaked at $140M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.